Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Mollie Uhrig"'
Homologous recombination (HR) is a complex DNA damage repair pathway and an attractive target of inhibition in anti-cancer therapy. To help guide the development of efficient HR inhibitors, it is critical to identify compensatory sub-pathways.In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff43ac279230358aff817ee52f6f6d2b
https://doi.org/10.1101/2021.07.15.452469
https://doi.org/10.1101/2021.07.15.452469